Herpes Zoster Infection Treatment Market to Grow with a CAGR of 3.89% through 2030F
Rising ongoing advancements in treatment options is
expected to drive the Global Herpes Zoster Infection Treatment Market growth in
the forecast period, 2026-2030.
According
to TechSci Research report, “Herpes Zoster Infection Treatment Market –
Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2030F”, the Global Herpes Zoster Infection Treatment Market
stood at USD 248.92 million in 2024 and is anticipated to grow with a CAGR of
3.89% in the forecast period, 2026-2030. The Global Herpes Zoster
Infection Treatment Market has been experiencing substantial growth in recent
years, driven by a convergence of factors that have reshaped the landscape of
herpes zoster infection management. One of the most significant drivers of
the global herpes zoster infection treatment market is the aging population. As
the world's demographic structure evolves, with an increasing number of
individuals reaching their senior years, the risk of herpes zoster infection
rises significantly. This heightened susceptibility is primarily attributed to
a weakened immune system in older adults, making them more prone to the
reactivation of the varicella-zoster virus. The aging demographic not only
increases the incidence of herpes zoster but also drives the demand for
effective treatments. Elderly individuals experiencing shingles often suffer
from severe pain and discomfort, making them more likely to seek medical
attention and treatment. Consequently, the expanding aging population serves as
a consistent and reliable driver for the growth of the herpes zoster infection
treatment market.
Another
crucial driver of the market is the increasing awareness about herpes zoster
infection among both healthcare professionals and the general public. In the
past, herpes zoster was often misdiagnosed or misunderstood, leading to delayed
treatment and inadequate management. However, with the dissemination of medical
knowledge and awareness campaigns, more individuals are now able to recognize
the symptoms of shingles and seek prompt medical care. Advancements in the
treatment of herpes zoster infection have revolutionized patient care and
further driven market growth. The availability of antiviral medications, such
as acyclovir, valacyclovir, and famciclovir, has been instrumental in reducing
the severity and duration of herpes zoster symptoms. These medications are
proven to be highly effective when administered promptly after the onset of the
infection. Pain management drugs, including opioids and anti-inflammatory
medications, have become integral components of herpes zoster treatment. They
help alleviate the excruciating pain and discomfort associated with the
condition, improving the overall quality of life for patients.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global Herpes Zoster Infection Treatment Market”
The
Global Herpes Zoster Infection Treatment Market is segmented into treatment type, route
of administration, distribution channel, regional distribution, and company.
Based
on the treatment type, prescription treatments are experiencing the fastest
growth compared to supporting treatments. This surge is primarily due to the
high efficacy of antiviral medications, such as acyclovir, valacyclovir, and
famciclovir, in reducing the severity and duration of herpes zoster infections.
These prescription antivirals specifically target the varicella-zoster virus,
controlling its replication and spread within the body. Their proven
effectiveness has led to widespread adoption among healthcare providers, thereby
driving market growth. The increasing global incidence of herpes zoster,
particularly among the aging population with weakened immune systems, has
escalated the demand for these targeted prescription therapies. The combination
of clinical efficacy and rising patient awareness contributes to the
accelerated expansion of the prescription treatment segment in the herpes
zoster infection treatment market.
Based
on region, The Asia-Pacific region is experiencing the fastest growth in the
global Herpes Zoster Infection Treatment Market, primarily due to its rapidly
aging population. As individuals age, their immune systems weaken, increasing
susceptibility to herpes zoster infections. Countries like China, Japan, and
India are witnessing significant increases in their elderly populations,
leading to a higher incidence of herpes zoster cases. The rising healthcare
awareness and improving access to medical services have led to earlier
diagnosis and treatment, further propelling market growth. Government
initiatives promoting vaccination and the presence of local pharmaceutical
manufacturers offering cost-effective treatment options also contribute to the
market's expansion in this region.
Major companies operating in Global Herpes Zoster
Infection Treatment Market are:
·
GSK plc.
·
Bausch Health Companies Inc.
·
Renata Limited
·
Novan, Inc.
·
Teva Pharmaceuticals USA, Inc.
·
Pfizer Inc.
·
Apotex Inc.
·
Sandoz Canada Inc.
·
Novartis Pharmaceuticals Corporation
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
“The
Global Herpes Zoster Infection Treatment Market is poised for significant
growth in the coming years due to several key factors. Firstly, the aging
global population is expanding, leading to a higher incidence of herpes zoster
cases as the elderly are more susceptible. Secondly, increased awareness and
education about herpes zoster, its complications, and the importance of early
treatment are encouraging individuals to seek medical care, driving market
demand. Thirdly, ongoing advancements in treatment options, including antiviral
medications and vaccines, are offering more effective and accessible solutions
for managing and preventing herpes zoster infections. Additionally, the high
economic burden of the disease is prompting investments in research and
development, spurring innovation in treatment modalities”, said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Herpes Zoster Infection Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Prescription Treatment, Supporting Treatment), By Route of administration (Oral, Intravenous, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region and Competition 2020-2030F", has evaluated the
future growth potential of Global Herpes Zoster Infection Treatment Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Herpes Zoster Infection Treatment
Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com